Peripheral Expression of Dopamine Genes as a Biomarker for Cocaine Addiction in Humans
Stacey Kigar1,2, Tsen Vei Lim1, Lorinda Turner1,2
1Department of Psychiatry, University of Cambridge, Cambridge, UK.
European Addiction Research
|February 21, 2026
Summary
Blood biomarkers, specifically DRD2 mRNA, show promise for diagnosing cocaine use disorder (CUD) and assessing related traits like impulsivity. This finding could aid in patient stratification for effective addiction treatment.
Area of Science:
- Neuroscience
- Genetics
- Addiction Medicine
Background:
- Objective measures are crucial for diagnosing addiction severity and stratifying patients for treatment.
- Dopamine-related biomarkers in blood require investigation for their predictive validity in cocaine use disorder (CUD).
Purpose of the Study:
- To investigate if blood-derived dopamine-related biomarkers can predict cocaine use disorder (CUD) severity.
- To explore the association between genetic variations in dopamine pathways and CUD.
Main Methods:
- A cross-sectional case-control study involving 349 participants (163 with CUD, 186 controls).
- Collected data on CUD-related traits, including impulsivity and sensation-seeking.
- Measured mRNA transcription of dopamine genes (DRD2, DRD3, DRD4, COMT) and specific risk alleles.
Main Results:
- Elevated DRD2 mRNA levels were observed in the peripheral blood of CUD patients (p=0.020).
- The DRD2 rs6277 risk allele was significantly associated with CUD diagnosis (OR=2.16, p=0.02).
- DRD2 mRNA levels correlated with self-reported impulsivity (p=0.013).
Conclusions:
- Blood-based DRD2 gene expression may serve as a valuable biomarker for CUD diagnosis.
- DRD2 biomarkers are potentially linked to CUD diagnosis and associated behavioral traits.
- Further research into dopamine-related biomarkers could enhance addiction treatment strategies.
Related Concept Videos
Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
974
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
974
Drugs Affecting Neurotransmitter Synthesis
2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K


